(R)-2-amino-4-methyl-1,1-dimethylpentanol | 944141-87-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (R)-2-amino-4-methyl-1,1-dimethylpentanol
• 英文别名: (R)-3-Amino-2,5-dimethylhexan-2-ol；(3R)-3-amino-2,5-dimethylhexan-2-ol
• CAS: 944141-87-1
• 化学式: C₈H₁₉NO
• 分子量: 145.245
• InChiKey: JSOXSSLAYMTIMV-SSDOTTSWSA-N

物化性质

• 沸点：
  230.8±13.0 °C(Predicted)
• 密度：
  0.893±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (R)-2-amino-4-methyl-1,1-dimethylpentanol 在 2-双环己基膦-2',6'-二甲氧基联苯 、 potassium phosphate 、 tin(II) chloride dihdyrate 、 palladium diacetate 、 N,N-二异丙基乙胺 作用下， 以 乙醇 、 二甲基亚砜 、 乙酸乙酯 、 甲苯 为溶剂， 反应 29.0h， 生成
  参考文献：
  名称：

  [EN] SPIROCHIRAL PLATINUM(II) AND PALLADIUM(II) COMPLEX CIRCULARLY POLARIZED LUMINESCENT MATERIAL AND USE THEREOF
  [FR] MATÉRIAU LUMINESCENT À POLARISATION CIRCULAIRE DE COMPLEXE DE PLATINE (II) ET DE PALLADIUM (II) SPIROCHIRAL ET SON UTILISATION
  [ZH] 螺手性铂（II）和钯（II）配合物圆偏振发光材料及应用

  摘要：

  公开了一种螺手性铂（II）和钯（II）配合物圆偏振发光材料及应用。所述螺手性金属配合物分子的形成，可通过配体中的中心手性片段自主诱导整个四齿配体以空间位阻小的方式和金属离子配位，形成光学纯的的螺手性金属配合物圆偏振光发光材料，此诱导反应具有立体专一性；螺手性金属配合物无需手性拆分；螺手性金属配合物材料具有高的化学稳定性和热稳定性。此类螺手性金属配合物在圆偏振发光元件及相关领域中具有重要应用。

  公开号：

  WO2024022294A1
• 作为产物：
  描述：

  BOC-D-亮氨酸甲酯 在 三氟乙酸 作用下， 以 四氢呋喃 、 氯仿 为溶剂， 反应 3.17h， 生成 (R)-2-amino-4-methyl-1,1-dimethylpentanol
  参考文献：
  名称：

  Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX₃CR1)

  摘要：

  We have developed two parallel series, A and B, of CX(3)CR1 antagonists for the treatment of multiple sclerosis. By modifying the substituents on the 7-amino-5-thio-thiazolo[4,5-d]-pyrimidine core structure, we were able to achieve compounds with high selectivity for CX(3)CR1 over the closely related CXCR2 receptor. The structure-activity relationships showed that a leucinol moiety attached to the core-structure in the 7-position together with alpha-methyl branched benzyl derivatives in the 5-position displayed promising affinity, and selectivity as well as physicochemical properties, as exemplified by compounds 18a and 24h. We show the preparation of the first potent and selective orally available CX(3)CR1 antagonists.

  DOI：

  10.1021/jm3012273

文献信息

• Organic Compounds
  申请人：Ehara Takeru

  公开号：US20090192148A1

  公开（公告）日：2009-07-30

  The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The compounds have the formula I′ wherein R1, R2, T, R3 and R4 areas defined in the specification.

  本发明涉及3,5-取代哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖肾素活性的疾病（=失调）；该类化合物用于制备治疗依赖肾素活性疾病的制剂；该类化合物用于治疗依赖肾素活性的疾病；包括3,5-取代哌啶化合物的制药配方和/或包括给予3,5-取代哌啶化合物的治疗方法，以及制造3,5-取代哌啶化合物的新型中间体和部分合成步骤。该化合物的式子为I'，其中R1、R2、T、R3和R4在规范中有定义。
• METHOD FOR PRODUCING OPTICALLY ACTIVE BISAMIDO ALCOHOL COMPOUND
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1698616A1

  公开（公告）日：2006-09-06

  It is provided that a method for producing an optically active bisamidoalcohol compound represented by the formula (3): wherein R1 represents a C1-6 alkyl group, an optionally substituted phenyl group, an optionally substituted aralkyl group or a hydrogen atom, or two R1s, which are bonded to the same carbon atom, are bonded to form a ring together with the carbon atom to which they are bonded, R2 represents a C1-6 alkyl group, an optionally substituted phenyl group, a 1-naphthyl group, a 2-naphthyl group or an optionally substituted aralkyl group, R3 and R4 are the same or different, and each represents a hydrogen atom or C1-3 alkyl group, m represents an integer of 0 to 2, and * represents an asymmetric center, which comprises reacting an optically active aminoalcohol compound represented by the formula (1): wherein R1, R2 and * are as defined above, with a diester compound represented by the formula (2): wherein R3, R4 and m are as defined above and R5 represents a C1-3 alkyl group, in the presence of a lithium compound.

  本发明提供了一种生产由式（3）代表的光学活性双氨基醇化合物的方法： 其中 R1 代表 C1-6 烷基、任选取代的苯基、任选取代的芳烷基或氢原子，或两个 R1 与同一碳原子键合，与其键合的碳原子一起形成环、 R2 代表 C1-6 烷基、任选取代的苯基、1-萘基、2-萘基或任选取代的芳基、 R3 和 R4 相同或不同，各自代表氢原子或 C1-3 烷基、 m 代表 0 至 2 的整数，以及 * 代表不对称中心，其中包括与由式（1）代表的光学活性氨基醇化合物反应： 其中 R1、R2 和 * 如上定义、 与式 (2) 所代表的二酯化合物反应： 其中 R3、R4 和 m 如上定义，R5 代表 C1-3 烷基、 在锂化合物存在下。
• METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENE BISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1698617A1

  公开（公告）日：2006-09-06

  It is provided to an optically active cycloalkylidenebisamidoalcohol compound represented by the formula (3): wherein R1 represents a C1-6 alkyl group, an optionally substituted phenyl group, an optionally substituted aralkyl group or a hydrogen atom, or two R1s, which are bonded to the same carbon atom, are bonded to form a ring together with the carbon atom to which they are bonded, R2 represents a C1-6 alkyl group, an optionally substituted aralkyl group or an optionally substituted phenyl group and * represents an asymmetric center, a method for producing it and a method for producing an optically active cycloalkylidenebisoxazoline compound represented by the formula (4): wherein R1, R2 and * are as defined above, using thereof.

  提供了一种由式（3）代表的具有光学活性的环烷基亚氨基双酰胺醇化合物： 其中R1代表C1-6烷基、任选取代的苯基、任选取代的芳烷基或氢原子，或两个R1，它们键合到同一个碳原子上，与它们所键合的碳原子一起形成一个环，R2代表C1-6烷基、任选取代的芳烷基或任选取代的苯基，*代表一个不对称中心，还提供了一种生产该化合物的方法和一种生产由式(4)表示的光学活性环烷亚基双噁唑啉化合物的方法： 其中 R1、R2 和 * 如上文所定义，使用它们。
• 3 , 5-substitued piperidine compounds as renin inhibitors
  申请人：Novartis AG

  公开号：EP2420491A1

  公开（公告）日：2012-02-22

  The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3, 5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The compounds (which can also be present as salts) have the formula I' wherein R1, R2, T, R3, R4, R7 and R8 are as defined in the specification and R6 is OH.

  本发明涉及3,5-取代的哌啶化合物，这些化合物用于温血动物的诊断和治疗，特别是用于治疗依赖于肾素活性的疾病（=紊乱）；使用该类化合物制备药物制剂，用于治疗依赖于肾素活性的疾病；该类化合物在治疗依赖于肾素活性的疾病中的用途；包含 3,5-取代的哌啶化合物的药物制剂，和/或包括施用 3,5-取代的哌啶化合物的治疗方法，3,5-取代的哌啶化合物的制造方法，及其合成的新型中间体和部分步骤。 这些化合物（也可以以盐的形式存在）具有式 I' 其中 R1、R2、T、R3、R4、R7 和 R8 如说明书中所定义，R6 为 OH。
• Method for producing optically active bisamidoalcohol compound
  申请人：Itagaki Makoto

  公开号：US20070100163A1

  公开（公告）日：2007-05-03

  It is provided that a method for producing an optically active bisamidoalcohol compound represented by the formula (3): wherein R 1 represents a C1-6 alkyl group, an optionally substituted phenyl group, an optionally substituted aralkyl group or a hydrogen atom, or two R 1 s, which are bonded to the same carbon atom, are bonded to form a ring together with the carbon atom to which they are bonded, R 2 represents a C1-6 alkyl group, an optionally substituted phenyl group, a 1-naphthyl group, a 2-naphthyl group or an optionally substituted aralkyl group, R 3 and R 4 are the same or different, and each represents a hydrogen atom or C1-3 alkyl group, m represents an integer of 0 to 2, and * represents an asymmetric center, which comprises reacting an optically active aminoalcohol compound represented by the formula (1): wherein R 1 , R 2 and * are as defined above, with a diester compound represented by the formula (2): wherein R 3 , R 4 and m are as defined above and R 5 represents a C1-3 alkyl group, in the presence of a lithium compound.